Enrique Espinosa

7PUBLICATIONS
73CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 07, 2026
Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study.

|Feb 27, 2026
NKGD2 Ligands (NKG2DLs) in Breast Cancer: In Silico Analysis and Narrative Review.

Jesús Peña-López, Angelo Gámez-Pozo, Lucía Trilla-Fuertes

|Nov 28, 2025
Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801.

Enrique Espinosa, Miguel-Ángel Berciano-Guerrero, Eva Muñoz-Couselo

|Dec 07, 2023
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.

Peter Schmid, Nicholas C Turner, Carlos H Barrios

|Sep 28, 2023
Predicting Risk of Severe Toxicity and Early Death in Older Adult Patients Treated with Chemotherapy.

Jaime Feliu, Ana Belén Custodio, Alvaro Pinto-Marín

|Sep 09, 2023
Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.

Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez

Pageof 2

Frequent Collaborators

2 joint publications

Joaquín Fra Rodríguez

2 joint publications

Elisabeth Pérez-Ruiz

2 joint publications

Angelo Gámez-Pozo

2 joint publications

Lucía Trilla-Fuertes